From the Philadelphia Inquirer, January 31, 2017
“Ben Franklin Technology Partners, the Philadelphia-based, state-backed startup/early-stage investment fund, says it’s spreading $2.3 million among 16 new and repeat companies set up by locally-based brains:
Jenrin Discovery Inc. (Ross. J. Chorvat, Wilmington, Del.) — developing “small-molecule drugs” that “selectively target peripheral receptors” for liver disease, diabetes, obesity. ..”
Features Penn startups: Shock Analytics, Sonosolve, Keriton, Cosy, and One Health Company